Pfizer lowers COVID-19 vaccine doses for younger kids in clinical trial


Pfizer lowers COVID-19 vaccine doses for younger kids in clinical trial



Pfizer said it has selected lower dosages of its COVID-19 vaccine for Phase 2/3 portions of its clinical trial involving kids younger than 11 than the volume given to shot recipients ages 12 and older.

Health Tips 5026751442209155010

Post a Comment

emo-but-icon
:noprob:
:smile:
:shy:
:trope:
:sneered:
:happy:
:escort:
:rapt:
:love:
:heart:
:angry:
:hate:
:sad:
:sigh:
:disappointed:
:cry:
:fear:
:surprise:
:unbelieve:
:shit:
:like:
:dislike:
:clap:
:cuff:
:fist:
:ok:
:file:
:link:
:place:
:contact:

Home item